It`s all about the scaffold, the work being done by Stratatech is on a collagen scaffold. That may put Polynovo and Dr Greenwood at an advantage in the development of CCS at least from a cost perspective and from the BTM results efficacy as well. What this BARDA contract shows is the amount of money that is being directed at artificial skin.$47.2mUS is more than market cap of CZD
From the Stratatech website
"The Company’s human tissue products are manufactured in a robust, highly reproducible process. In simplified terms, a dermal layer is formed by plating a mixture of collagen and fibroblast cells using standard tissue culture techniques"
- Forums
- ASX - By Stock
- CZD
- chart
chart, page-69
-
- There are more pages in this discussion • 62 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)